| Ratings | Buy | Hold | Sell | Other ratings | Last Close | Average Target | Upside | High Target | Low Target |
|---|---|---|---|---|---|---|---|---|---|
| (m) | (m) | (m) | (m) | (m) | $83.84 | (m) | (m) | (m) | (m) |
| Date | Stock | Analyst | Firm | Price When Rated | Price Target | Upside / Downside | Rating | Performance |
|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $104.42 | $108.00 | +3.43% | Overweight | |
| 2026-05-26 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $93.26 | $106.00 | +13.66% | Overweight | |
| 2026-05-06 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $86.86 | $101.00 | +16.28% | Overweight | |
| 2025-12-10 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $76.53 | $93.00 | +21.52% | Overweight | |
| 2025-09-04 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $73.32 | $87.00 | +18.66% | Overweight | |
| 2025-07-31 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $62.10 | $80.00 | +28.82% | Overweight | |
| 2025-06-02 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $64.04 | $79.00 | +23.36% | Overweight | |
| 2025-05-01 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $66.71 | $82.00 | +22.92% | Overweight | |
| 2025-02-12 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $55.00 | $73.00 | +32.73% | Overweight | |
| 2024-11-06 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $55.34 | $71.00 | +28.30% | Overweight | |
| 2024-10-23 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $56.85 | $75.00 | +31.93% | Overweight | |
| 2024-10-10 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $65.97 | $82.00 | +24.30% | Overweight | |
| 2024-08-07 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $56.47 | $63.00 | +11.56% | Equal Weight | |
| 2024-06-18 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $61.09 | $65.00 | +6.40% | Equal Weight | |
| 2024-05-02 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $56.31 | $63.00 | +11.88% | Equal Weight | |
| 2024-03-05 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $73.71 | $78.00 | +5.82% | Equal Weight | |
| 2023-10-06 | CVS CVS HEALTH Corp | Andrew Mok, CFA | Barclays | $69.75 | Overweight |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |